Who invested in Epigenic Therapeutics?
Epigenic Therapeutics's investors include Qiming Venture Partners, OrbiMed and Morningside Group.
Who invested in Epigenic Therapeutics
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $60MSept 2025
- Investors
- 3
The rounds
- Sept 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Epigenic Therapeutics
How much has Epigenic Therapeutics raised?
Epigenic Therapeutics has raised $60M across 1 round since 2025.
When did Epigenic Therapeutics last raise?
Epigenic Therapeutics's most recent round was a Series B of $60M in Sept 2025.
What was Epigenic Therapeutics's biggest round?
Its most recent round, $60M in Sept 2025, is also its largest on record.
Who backed Epigenic Therapeutics first?
Epigenic Therapeutics's first round on record, in Sept 2025, was backed by Qiming Venture Partners, OrbiMed and Morningside Group.
What stage is Epigenic Therapeutics at?
Epigenic Therapeutics's latest named round is a Series B, in Sept 2025.
Companies like Epigenic Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.